ZA9510195B - Monoclonal antibody fragments having immunosuppressant activity - Google Patents

Monoclonal antibody fragments having immunosuppressant activity

Info

Publication number
ZA9510195B
ZA9510195B ZA9510195A ZA9510195A ZA9510195B ZA 9510195 B ZA9510195 B ZA 9510195B ZA 9510195 A ZA9510195 A ZA 9510195A ZA 9510195 A ZA9510195 A ZA 9510195A ZA 9510195 B ZA9510195 B ZA 9510195B
Authority
ZA
South Africa
Prior art keywords
monoclonal antibody
antibody fragments
immunosuppressant activity
immunosuppressant
activity
Prior art date
Application number
ZA9510195A
Other languages
English (en)
Inventor
Zoltan Nagy
Damir Vidovic
Original Assignee
Hoffman La Roche A G F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffman La Roche A G F filed Critical Hoffman La Roche A G F
Publication of ZA9510195B publication Critical patent/ZA9510195B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9510195A 1994-12-07 1995-11-30 Monoclonal antibody fragments having immunosuppressant activity ZA9510195B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07

Publications (1)

Publication Number Publication Date
ZA9510195B true ZA9510195B (en) 1996-06-07

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9510195A ZA9510195B (en) 1994-12-07 1995-11-30 Monoclonal antibody fragments having immunosuppressant activity

Country Status (19)

Country Link
EP (1) EP0787151A1 (fi)
JP (1) JP2001506122A (fi)
CN (1) CN1168679A (fi)
AR (1) AR002005A1 (fi)
AU (1) AU4256096A (fi)
BR (1) BR9509902A (fi)
CA (1) CA2206471A1 (fi)
CO (1) CO4480041A1 (fi)
CZ (1) CZ172497A3 (fi)
FI (1) FI972430A (fi)
HU (1) HUT77342A (fi)
IL (1) IL116228A0 (fi)
MA (1) MA23739A1 (fi)
NO (1) NO972522L (fi)
PE (1) PE52996A1 (fi)
PL (1) PL320610A1 (fi)
TR (1) TR199501542A2 (fi)
WO (1) WO1996017874A1 (fi)
ZA (1) ZA9510195B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (en) * 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
WO2000012560A1 (en) * 1998-08-28 2000-03-09 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
DE60035337T2 (de) * 2000-05-12 2008-02-28 Gpc Biotech Ag Humane Peptide/Proteine, die das Töten von Zellen, einschliesslich lymphoider Tumorzellen, herbeiführen oder bewirken
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins
US20030096285A1 (en) 2001-10-11 2003-05-22 Tso J. Yun Identifying anti-tumor targets or agents by lipid raft immunization and proteomics
JP3665324B2 (ja) 2001-10-15 2005-06-29 麒麟麦酒株式会社 抗ｈｌａ−ｄｒ抗体
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
AU2011235328A1 (en) * 2010-04-01 2012-09-27 Immunomedics, Inc. Antibody-based depletion of antigen-presenting cells and dendritic cells
KR102647825B1 (ko) * 2021-07-22 2024-03-14 서울대학교산학협력단 항-hla-dp 단클론 항체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3269354D1 (en) * 1981-06-25 1986-04-03 Univ Leland Stanford Junior Allele specific immunotherapeutic method and dosage form
WO1991010722A2 (en) * 1989-12-27 1991-07-25 Centocor, Inc. Chimeric immunoglobulin for cd4 receptors
SK285046B6 (sk) * 1991-07-25 2006-05-04 Idec Pharmaceuticals Corporation Chimérna protilátka, ktorá sa špecificky viaže na ľudský antigén, farmaceutický prostriedok s jej obsahom, spôsob jej výroby a použitie

Also Published As

Publication number Publication date
CZ172497A3 (en) 1997-10-15
MA23739A1 (fr) 1996-07-01
BR9509902A (pt) 1997-10-21
TR199501542A2 (tr) 1996-07-21
FI972430A0 (fi) 1997-06-06
PE52996A1 (es) 1996-12-12
AU4256096A (en) 1996-06-26
MX9704225A (es) 1997-09-30
PL320610A1 (en) 1997-10-13
WO1996017874A1 (en) 1996-06-13
HUT77342A (hu) 1998-03-30
JP2001506122A (ja) 2001-05-15
NO972522D0 (no) 1997-06-03
CA2206471A1 (en) 1996-06-13
CO4480041A1 (es) 1997-07-09
AR002005A1 (es) 1998-01-07
FI972430A (fi) 1997-06-06
NO972522L (no) 1997-08-06
CN1168679A (zh) 1997-12-24
IL116228A0 (en) 1996-03-31
EP0787151A1 (en) 1997-08-06

Similar Documents

Publication Publication Date Title
HU9503638D0 (en) Anti-alpha-v-integrin monoclonal antibody
IL128406A0 (en) Monoclonal antibodies
ZA959336B (en) Antibodies
IL136335A0 (en) Monoclonal human natural antibodies
GB9603256D0 (en) Antibodies
AU1289795A (en) Monoclonal antibodies specific for human interleukin-5
EP0870826A4 (en) NEW PROTEINS AND MONOCLONAL ANTIBODIES AGAINST THESE
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
GB9412166D0 (en) Retargetting antibodies
ZA9510195B (en) Monoclonal antibody fragments having immunosuppressant activity
HUP9800613A3 (en) Humanized antibody against human fas-antigene
EP0977590A4 (en) HUMAN MONOCLONAL ANTIBODIES
EP0909278A4 (en) IMMUNOGLOBULIN G LINKED TO NEPHROPATHY AND ANTIBODIES AGAINST IT
ZA951113B (en) Tumor assosiated monoclonal antibody 123av16
GB9718911D0 (en) Monoclonal antibodies
EP0654532A4 (en) ANTIMUCOGLYCOPROTEIN MONOCLONAL ANTIBODIES.
PL329866A1 (en) Monoclonal antibody against human mp52
GB9615027D0 (en) Monoclonal antibodies
ZA9610336B (en) Anti-cd6 monoclonal antibodies and their uses
SI0742795T1 (en) Immuno-stimulatory monoclonal antibodies
GB9402593D0 (en) Antibody fragments
GB9406243D0 (en) Antibodies
GB9406222D0 (en) Huminised antibodies
GB9415331D0 (en) Antibodies
GB9506646D0 (en) Antibody